Bracketing wires for preoperative breast needle localization.
L Liberman, J Kaplan, K J Van Zee...
https://pubmed.ncbi.nlm.nih.gov/11517048/Actively Recruiting
Led by King Faisal Specialist Hospital & Research Center · Updated on 2026-09-28
35
Participants Needed
1
Research Sites
52 weeks
Total Duration
Breast cancer is the most common cancer affecting women worldwide, and early-stage breast cancer is typically treated with breast-conserving surgery and sentinel lymph node biopsy to minimize surgical impact while ensuring complete tumor removal and accurate staging. This study evaluates the use of Super Paramagnetic Iron Oxide SPIO, specifically Magtrace, as a single agent for both bracketing the tumor area and localizing the sentinel lymph node. The goal is to test whether this dual-purpose approach is feasible and effective compared to current methods that use multiple localization tools. Participants who need bracketing for wide local excision along with sentinel lymph node biopsy will receive Magtrace injections at four points around the tumor area one day before surgery under ultrasound or mammographic guidance. On the day of surgery, surgeons will use a magnetic probe to locate the Magtrace signal for both the lesion and sentinel lymph node. If localization fails, alternative methods may be used. Surgery will follow standard techniques, and a blue dye will also be used to confirm sentinel node detection. The study aims to recruit 35 patients for this prospective pilot trial. During the study, participants will undergo localization procedures before surgery, surgical excision, and sentinel node biopsy with ongoing monitoring of localization success, surgical duration, tissue removal, margin status, reoperation rates, and postoperative complications up to three months. Data on clinical outcomes, complications, and cost will be collected and analyzed. The study will last approximately 2 to 3 years, including recruitment and follow-up, with results intended for publication and broader sharing.
CONDITIONS
Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer
F
Fayyaz A Mazari, MBBS, MSc, MS, PhD, FRCS, FEBS
Z
Zabihullah Khan, MBBS FRCS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
King Faisal Specialist Hospital & Research Center
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
netral
Duration - 1 day before surgery
Participants receive Magtrace injections at four points around the tumor area under image guidance one day before surgery for lesion bracketing and sentinel lymph node marking.
1 visit
Duration - Day of surgery
On the day of surgery, participants undergo breast conserving surgery with magnetic probe guidance to locate the Magtrace signal for lesion excision and sentinel lymph node biopsy using a blue dye as a second tracer.
1 visit
Duration - 3 months
Participants are monitored for surgical outcomes including resection margins, complications, and potential need for reoperation over three months following surgery.
Follow-up visits as scheduled
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
L Liberman, J Kaplan, K J Van Zee...
https://pubmed.ncbi.nlm.nih.gov/11517048/Billy Ho Hung Cheung, Michael Co, Tsz Tsun Natalie Lui...
https://pubmed.ncbi.nlm.nih.gov/38751684/Katie M Davis, Courtney P Raybon, Natasha Monga...
https://pubmed.ncbi.nlm.nih.gov/38424951/Inés Torras, Isaac Cebrecos, Helena Castillo...
https://pubmed.ncbi.nlm.nih.gov/38601289/Walker Lyons, Ryan Lamm, Emily R Duffner...
https://pubmed.ncbi.nlm.nih.gov/35758520/M Ahmed, B Anninga, S Goyal...
https://pubmed.ncbi.nlm.nih.gov/25868072/Monica Da Silva, Jessica Porembka, Ali A Mokdad...
https://pubmed.ncbi.nlm.nih.gov/28707718/King Faisal Specialist Hospital & Research Center
Lead Sponsor